January 26, 2016 / 11:53 AM / 2 years ago

BRIEF-Grifols invests in project to treat HIV

Jan 26 (Reuters) - Grifols SA :

* Invests in the project led by Albajuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, to fund development of therapeutic antibodies against HIV

* Says it will initially invest 3.75 million euros ($4.1 million), although its total investment in the project could increase as each development stage is completed Further company coverage: ($1 = 0.9236 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below